Shenzhen Noposion Crop Science Co., Ltd. (SHE:002215)
9.46
-0.22 (-2.27%)
Apr 30, 2025, 3:04 PM CST
SHE:002215 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 5,288 | 4,103 | 4,250 | 4,477 | 4,113 | Upgrade
|
Other Revenue | - | 16.45 | 15.08 | 23.87 | 17.95 | Upgrade
|
Revenue | 5,288 | 4,120 | 4,265 | 4,501 | 4,131 | Upgrade
|
Revenue Growth (YoY) | 28.37% | -3.41% | -5.23% | 8.94% | 1.80% | Upgrade
|
Cost of Revenue | 3,296 | 2,916 | 3,121 | 3,297 | 3,092 | Upgrade
|
Gross Profit | 1,992 | 1,203 | 1,144 | 1,203 | 1,039 | Upgrade
|
Selling, General & Admin | 976.4 | 684.85 | 643.71 | 703.1 | 658.72 | Upgrade
|
Research & Development | 142.95 | 118.9 | 125.62 | 107.38 | 99.03 | Upgrade
|
Other Operating Expenses | -29.74 | 13.89 | 16 | 12.89 | 10.84 | Upgrade
|
Operating Expenses | 1,090 | 907.4 | 835.49 | 861.85 | 824.61 | Upgrade
|
Operating Income | 902.16 | 295.85 | 308.7 | 341.63 | 214.44 | Upgrade
|
Interest Expense | - | -97.56 | -96.85 | -68.06 | -66.68 | Upgrade
|
Interest & Investment Income | 47.44 | 51.05 | 81.57 | 47.04 | 31.5 | Upgrade
|
Currency Exchange Gain (Loss) | - | 1.12 | 0.01 | -1.09 | -2.74 | Upgrade
|
Other Non Operating Income (Expenses) | -255.46 | -23.4 | -11.37 | -10.02 | -2.59 | Upgrade
|
EBT Excluding Unusual Items | 694.15 | 227.06 | 282.06 | 309.5 | 173.93 | Upgrade
|
Impairment of Goodwill | - | -9.21 | -14.48 | -10.41 | -5.48 | Upgrade
|
Gain (Loss) on Sale of Investments | - | -13.4 | - | -7.11 | -11.46 | Upgrade
|
Gain (Loss) on Sale of Assets | -16.73 | -0.46 | 28.81 | 8.18 | -0.53 | Upgrade
|
Asset Writedown | -107.12 | -22.57 | -9.21 | -12.03 | -1.29 | Upgrade
|
Other Unusual Items | - | 35.58 | 57.48 | 54.87 | 38.86 | Upgrade
|
Pretax Income | 570.3 | 217 | 344.66 | 343.01 | 194.03 | Upgrade
|
Income Tax Expense | 9.2 | 12.43 | 17.48 | 45.74 | 19.35 | Upgrade
|
Earnings From Continuing Operations | 561.1 | 204.57 | 327.18 | 297.26 | 174.68 | Upgrade
|
Minority Interest in Earnings | 23.49 | 31.06 | 1.26 | 8.07 | -7.77 | Upgrade
|
Net Income | 584.59 | 235.63 | 328.44 | 305.33 | 166.91 | Upgrade
|
Net Income to Common | 584.59 | 235.63 | 328.44 | 305.33 | 166.91 | Upgrade
|
Net Income Growth | 148.10% | -28.26% | 7.57% | 82.93% | -29.28% | Upgrade
|
Shares Outstanding (Basic) | 996 | 978 | 977 | 903 | 899 | Upgrade
|
Shares Outstanding (Diluted) | 1,020 | 1,003 | 996 | 919 | 911 | Upgrade
|
Shares Change (YoY) | 1.75% | 0.62% | 8.38% | 0.91% | 0.76% | Upgrade
|
EPS (Basic) | 0.59 | 0.24 | 0.34 | 0.34 | 0.19 | Upgrade
|
EPS (Diluted) | 0.57 | 0.23 | 0.33 | 0.33 | 0.18 | Upgrade
|
EPS Growth | 143.83% | -28.70% | -0.75% | 81.28% | -29.81% | Upgrade
|
Free Cash Flow | 118.08 | -344.92 | -730.27 | -84.68 | 286.1 | Upgrade
|
Free Cash Flow Per Share | 0.12 | -0.34 | -0.73 | -0.09 | 0.31 | Upgrade
|
Dividend Per Share | - | 0.150 | 0.150 | 0.200 | 0.100 | Upgrade
|
Dividend Growth | - | - | -25.00% | 100.00% | -33.33% | Upgrade
|
Gross Margin | 37.66% | 29.21% | 26.83% | 26.74% | 25.15% | Upgrade
|
Operating Margin | 17.06% | 7.18% | 7.24% | 7.59% | 5.19% | Upgrade
|
Profit Margin | 11.05% | 5.72% | 7.70% | 6.78% | 4.04% | Upgrade
|
Free Cash Flow Margin | 2.23% | -8.37% | -17.12% | -1.88% | 6.93% | Upgrade
|
EBITDA | 1,275 | 515.57 | 439.55 | 458.02 | 314.96 | Upgrade
|
EBITDA Margin | 24.11% | 12.52% | 10.31% | 10.18% | 7.62% | Upgrade
|
D&A For EBITDA | 373.03 | 219.73 | 130.85 | 116.4 | 100.52 | Upgrade
|
EBIT | 902.16 | 295.85 | 308.7 | 341.63 | 214.44 | Upgrade
|
EBIT Margin | 17.06% | 7.18% | 7.24% | 7.59% | 5.19% | Upgrade
|
Effective Tax Rate | 1.61% | 5.73% | 5.07% | 13.34% | 9.97% | Upgrade
|
Revenue as Reported | - | 4,120 | 4,265 | 4,501 | 4,131 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.